Related references
Note: Only part of the references are listed.Lactate promotes macrophage HMGB1 lactylation, acetylation, and exosomal release in polymicrobial sepsis
Kun Yang et al.
CELL DEATH AND DIFFERENTIATION (2022)
The Neuroimmunology of Chronic Pain: From Rodents to Humans
Peter M. Grace et al.
JOURNAL OF NEUROSCIENCE (2021)
Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy
Pascale Hubert et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
HMGB1 released from nociceptors mediates inflammation
Huan Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Neuronal HMGB1 in nucleus accumbens regulates cocaine reward memory
Shuang-Qi Gao et al.
ADDICTION BIOLOGY (2020)
Chronic morphine-mediated upregulation of high mobility group box 1 in the spinal cord contributes to analgesic tolerance and hyperalgesia in rats
Junliang Qian et al.
NEUROTHERAPEUTICS (2020)
Targeting Inflammation Driven by HMGB1
Huan Yang et al.
FRONTIERS IN IMMUNOLOGY (2020)
HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic Opportunities
Yam Nath Paudel et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
High Mobility Group Box-1 and Blood-Brain Barrier Disruption
Masahiro Nishibori et al.
CELLS (2020)
Anti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases
Masahiro Nishibori et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2019)
Cutaneous TRPV1+ Neurons Trigger Protective Innate Type 17 Anticipatory Immunity
Jonathan A. Cohen et al.
CELL (2019)
Cartilage-binding antibodies induce pain through immune complex-mediated activation of neurons
Alex Bersellini Farinotti et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Spinal high-mobility group box-1 induces long-lasting mechanical hypersensitivity through the toll-like receptor 4 and upregulation of interleukin-1β in activated astrocytes
Norimitsu Morioka et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Evidence of a role for spinal HMGB1 in ischemic stress-induced mechanical allodynia in mice
Wataru Matsuura et al.
BRAIN RESEARCH (2018)
Extracellular HMGB1 as a therapeutic target in inflammatory diseases
Ulf Andersson et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
Exploring the biological functional mechanism of the HMGB1/TLR4/MD-2 complex by surface plasmon resonance (vol 24, 21, 2018)
Mingzhu He et al.
MOLECULAR MEDICINE (2018)
Identification of cytokine-specific sensory neural signals by decoding murine vagus nerve activity
Theodoros P. Zanos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Glycyrrhizin Protects Mice Against Experimental Autoimmune Encephalomyelitis by Inhibiting High-Mobility Group Box 1 (HMGB1) Expression and Neuronal HMGB1 Release
Yan Sun et al.
FRONTIERS IN IMMUNOLOGY (2018)
Molecular and Functional Neuroscience in Immunity
Valentin A. Pavlov et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
Complex Role of Capsaicin-Sensitive Afferents in the Collagen Antibody-Induced Autoimmune Arthritis of the Mouse
Eva Borbely et al.
SCIENTIFIC REPORTS (2018)
The Endotoxin Delivery Protein HMGB1 Mediates Caspase-11-Dependent Lethality in Sepsis
Meihong Deng et al.
IMMUNITY (2018)
The crucial roles of inflammatory mediators in inflammation: A review
L. A. Abdulkhaleq et al.
VETERINARY WORLD (2018)
Mechanisms and Therapeutic Relevance of Neuro-immune Communication
Sangeeta S. Chavan et al.
IMMUNITY (2017)
Neural regulation of immunity: molecular mechanisms and clinical translation
Valentin A. Pavlov et al.
NATURE NEUROSCIENCE (2017)
Therapeutic effects of anti-HMGB1 monoclonal antibody on pilocarpine-induced status epilepticus in mice
Li Fu et al.
SCIENTIFIC REPORTS (2017)
Anti-high mobility group box-1 (HMGB1) antibody inhibits hemorrhage-induced brain injury and improved neurological deficits in rats
Dengli Wang et al.
SCIENTIFIC REPORTS (2017)
Therapeutic potential of an anti-high mobility group box-1 monoclonal antibody in epilepsy
Junli Zhao et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease
Tatsuya Sasaki et al.
EXPERIMENTAL NEUROLOGY (2016)
Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation
Bruno Bonaz et al.
JOURNAL OF PHYSIOLOGY-LONDON (2016)
Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis
Frieda A. Koopman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Neural circuits for pain: Recent advances and current views
Cedric Peirs et al.
SCIENCE (2016)
The Emerging Role of HMGB1 in Neuropathic Pain: A Potential Therapeutic Target for Neuroinflammation
Wenbin Wan et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Systemic HMGB1 Neutralization Prevents Postoperative Neurocognitive Dysfunction in Aged Rats
Niccolo Terrando et al.
FRONTIERS IN IMMUNOLOGY (2016)
O envolvimento do nervo mediano na artrite reumatoide tem sido excessivamente valorizado?
Rajalingham Sakthiswary et al.
Revista Brasileira De Reumatologia (2016)
HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer's disease
Kyota Fujita et al.
SCIENTIFIC REPORTS (2016)
Anti-high mobility group box-1 (HMGB1) antibody attenuates delayed cerebral vasospasm and brain injury after subarachnoid hemorrhage in rats
Jun Haruma et al.
SCIENTIFIC REPORTS (2016)
Phenotypic changes in dorsal root ganglion and spinal cord in the collagen antibody-induced arthritis mouse model
Jie Su et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2015)
MD-2 is required for disulfide HMGB1-dependent TLR4 signaling
Huan Yang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Axonal Amphoterin mRNA Is Regulated by Translational Control and Enhances Axon Outgrowth
Tanuja T. Merianda et al.
JOURNAL OF NEUROSCIENCE (2015)
Ethanol directly induced HMGB1 release through NOX2/NLRP1 inflammasome in neuronal cells
Xiaolan Wang et al.
TOXICOLOGY (2015)
Early release of high-mobility group box 1 (HMGB1) from neurons in experimental subarachnoid hemorrhage in vivo and in vitro
Qing Sun et al.
JOURNAL OF NEUROINFLAMMATION (2014)
HMGB1 in health and disease
Rui Kang et al.
MOLECULAR ASPECTS OF MEDICINE (2014)
Spinal HMGB1 induces TLR4-mediated long-lasting hypersensitivity and glial activation and regulates pain-like behavior in experimental arthritis
Nilesh M. Agalave et al.
PAIN (2014)
Release of Neuronal HMGB1 by Ethanol through Decreased HDAC Activity Activates Brain Neuroimmune Signaling
Jian Y. Zou et al.
PLOS ONE (2014)
Extracellular High-Mobility Group Box 1 Protein (HMGB1) as a Mediator of Persistent Pain
Nilesh M. Agalave et al.
MOLECULAR MEDICINE (2014)
Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis
A. Uzawa et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis
Andrew P. Robinson et al.
JOURNAL OF AUTOIMMUNITY (2013)
Neuropathic Pain in Rats with a Partial Sciatic Nerve Ligation Is Alleviated by Intravenous Injection of Monoclonal Antibody to High Mobility Group Box-1
Yoki Nakamura et al.
PLOS ONE (2013)
Spreading Depression Triggers Headache by Activating Neuronal Panx1 Channels
Hulya Karatas et al.
SCIENCE (2013)
Anti-high mobility group box-1 antibody therapy for traumatic brain injury
Yu Okuma et al.
ANNALS OF NEUROLOGY (2012)
HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4
Milena Schiraldi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
Emilie Venereau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
The persistent release of HMGB1 contributes to tactile hyperalgesia in a rodent model of neuropathic pain
Polina Feldman et al.
JOURNAL OF NEUROINFLAMMATION (2012)
HMGB1 Mediates Cognitive Impairment in Sepsis Survivors
Sangeeta S. Chavan et al.
MOLECULAR MEDICINE (2012)
HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection
Ulf Andersson et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Anti-HMGB1 Neutralization Antibody Improves Pain-Related Behavior Induced by Application of Autologous Nucleus Pulposus Onto Nerve Roots in Rats
Ken-ichi Otoshi et al.
SPINE (2011)
Anti-high Mobility Group Box-1 Monoclonal Antibody Protects the Blood-Brain Barrier From Ischemia-Induced Disruption in Rats
Jiyong Zhang et al.
STROKE (2011)
A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release
Huan Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats
Keyue Liu et al.
FASEB JOURNAL (2007)
High mobility group box I protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo
G. Faraco et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Protective effect of sensory denervation in inflammatory arthritis (evidence of regulatory neuroimmune pathways in the arthritic joint)
D Kane et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway
S Gardella et al.
EMBO REPORTS (2002)
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
LV Borovikova et al.
NATURE (2000)
Share Paper
